Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current REPH market cap is 219.01M. The company's latest EPS is USD -0.1267 and P/E is -8.68.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 99.22M | 66.5M | 75.36M | 90.21M | 94.64M |
| Operating Income | 25.75M | -8.34M | 412k | 279k | -3.57M |
| Net Income | -18.63M | -27.5M | -11.37M | -19.88M | -13.27M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 110.46M | 103.42M | 160.32M | 157.44M | 153.47M |
| Total Liabilities | 117.17M | 117.52M | 118.25M | 97.58M | 94.81M |
| Total Equity | -6.71M | -14.1M | 42.06M | 59.86M | 58.66M |
| Market Cap | 219.01M |
| Price to Earnings Ratio | -8.68 |
| Price to Sales Ratio | 1.22 |
| Price to Cash Ratio | 14.23 |
| Price to Book Ratio | 1.96 |
| Dividend Yield | - |
| Shares Outstanding | 104.79M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.11 (5.24%) |
| Company Name | Recro Pharma Inc |
| Address |
1 e. uwchlan ave exton, pennsylvania 19341 |
| Website | https://www.societalcdmo.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
